These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29182711)

  • 1. Evaluation of the Neuroprotective Potential of N-Acetylcysteine for Prevention and Treatment of Cognitive Aging and Dementia.
    Hara Y; McKeehan N; Dacks PA; Fillit HM
    J Prev Alzheimers Dis; 2017; 4(3):201-206. PubMed ID: 29182711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview on the Effects of
    Tardiolo G; Bramanti P; Mazzon E
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30551603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of N-acetylcysteine in the treatment of schizophrenia].
    Miyake N; Miyamoto S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2016 Apr; 36(2):29-35. PubMed ID: 27333656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine.
    Sunitha K; Hemshekhar M; Thushara RM; Santhosh MS; Yariswamy M; Kemparaju K; Girish KS
    Free Radic Res; 2013 May; 47(5):357-67. PubMed ID: 23472882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI.
    Pandya JD; Readnower RD; Patel SP; Yonutas HM; Pauly JR; Goldstein GA; Rabchevsky AG; Sullivan PG
    Exp Neurol; 2014 Jul; 257():106-13. PubMed ID: 24792639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which?
    Lockhart BP; Lestage PJ
    Exp Gerontol; 2003; 38(1-2):119-28. PubMed ID: 12543269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin.
    da Costa M; Bernardi J; Costa L; Fiuza T; Brandão R; Ribeiro MF; Amaral JD; Rodrigues CMP; Pereira ME
    Chem Biol Interact; 2017 Jun; 272():37-46. PubMed ID: 28499986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderly.
    McCarty MF; DiNicolantonio JJ
    Age (Dordr); 2015 Oct; 37(5):96. PubMed ID: 26362762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of cognitive function in schizophrenia with
    Yolland COB; Phillipou A; Castle DJ; Neill E; Hughes ME; Galletly C; Smith ZM; Francis PS; Dean OM; Sarris J; Siskind D; Harris AWF; Rossell SL
    Nutr Neurosci; 2020 Feb; 23(2):139-148. PubMed ID: 29847303
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic profile of N-acetylcysteine amide and its main metabolite in mice using new analytical method.
    He R; Zheng W; Ginman T; Ottosson H; Norgren S; Zhao Y; Hassan M
    Eur J Pharm Sci; 2020 Feb; 143():105158. PubMed ID: 31740394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status.
    Zhou J; Coles LD; Kartha RV; Nash N; Mishra U; Lund TC; Cloyd JC
    J Pharm Sci; 2015 Aug; 104(8):2619-26. PubMed ID: 26052837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine amide, a promising antidote for acetaminophen toxicity.
    Khayyat A; Tobwala S; Hart M; Ercal N
    Toxicol Lett; 2016 Jan; 241():133-42. PubMed ID: 26602168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases.
    Banaclocha MM
    Med Hypotheses; 2001 Apr; 56(4):472-7. PubMed ID: 11339849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early preservation of mitochondrial bioenergetics supports both structural and functional recovery after neurotrauma.
    Semple BD
    Exp Neurol; 2014 Nov; 261():291-7. PubMed ID: 25079371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial.
    Skvarc DR; Dean OM; Byrne LK; Gray LJ; Ives K; Lane SE; Lewis M; Osborne C; Page R; Stupart D; Turner A; Berk M; Marriott AJ
    Trials; 2016 Aug; 17():395. PubMed ID: 27502769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of N-acetylcysteine (NAC) on human cognition - A systematic review.
    Skvarc DR; Dean OM; Byrne LK; Gray L; Lane S; Lewis M; Fernandes BS; Berk M; Marriott A
    Neurosci Biobehav Rev; 2017 Jul; 78():44-56. PubMed ID: 28438466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Phycocyanin protects against acute tributyltin chloride neurotoxicity by modulating glial cell activity along with its anti-oxidant and anti-inflammatory property: A comparative efficacy evaluation with N-acetyl cysteine in adult rat brain.
    Mitra S; Siddiqui WA; Khandelwal S
    Chem Biol Interact; 2015 Aug; 238():138-50. PubMed ID: 26079211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of N-acetylcysteine amide (NACA), a thiol antioxidant on radiation-induced cytotoxicity in Chinese hamster ovary cells.
    Wu W; Abraham L; Ogony J; Matthews R; Goldstein G; Ercal N
    Life Sci; 2008 May; 82(21-22):1122-30. PubMed ID: 18448127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.